GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,344,000 | -2.2% | 30,869 | -2.1% | 0.04% | 0.0% |
Q1 2022 | $1,374,000 | +1.1% | 31,545 | +2.4% | 0.04% | +5.0% |
Q4 2021 | $1,359,000 | +41.1% | 30,810 | +22.3% | 0.04% | +29.0% |
Q3 2021 | $963,000 | +60.8% | 25,195 | +67.5% | 0.03% | +47.6% |
Q2 2021 | $599,000 | -0.7% | 15,040 | -11.0% | 0.02% | -16.0% |
Q1 2021 | $603,000 | -15.5% | 16,890 | -13.0% | 0.02% | -26.5% |
Q4 2020 | $714,000 | -53.9% | 19,404 | -52.9% | 0.03% | -64.6% |
Q3 2020 | $1,550,000 | +23.0% | 41,178 | +33.3% | 0.10% | +5.5% |
Q2 2020 | $1,260,000 | +19.2% | 30,884 | +10.7% | 0.09% | -7.1% |
Q1 2020 | $1,057,000 | -12.3% | 27,899 | +8.8% | 0.10% | -3.9% |
Q4 2019 | $1,205,000 | +155.8% | 25,650 | +132.3% | 0.10% | +92.5% |
Q3 2019 | $471,000 | +109.3% | 11,043 | +96.0% | 0.05% | +82.8% |
Q2 2019 | $225,000 | -18.2% | 5,634 | -14.5% | 0.03% | -38.3% |
Q1 2019 | $275,000 | +30.3% | 6,586 | +25.4% | 0.05% | -34.7% |
Q2 2018 | $211,000 | +2.9% | 5,252 | -0.7% | 0.07% | -12.2% |
Q1 2018 | $205,000 | -16.3% | 5,287 | -19.4% | 0.08% | -21.9% |
Q4 2017 | $245,000 | – | 6,556 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |